220 related articles for article (PubMed ID: 22203988)
1. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).
Kanashiro-Takeuchi RM; Takeuchi LM; Rick FG; Dulce R; Treuer AV; Florea V; Rodrigues CO; Paulino EC; Hatzistergos KE; Selem SM; Gonzalez DR; Block NL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):559-63. PubMed ID: 22203988
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction.
Kanashiro-Takeuchi RM; Tziomalos K; Takeuchi LM; Treuer AV; Lamirault G; Dulce R; Hurtado M; Song Y; Block NL; Rick F; Klukovits A; Hu Q; Varga JL; Schally AV; Hare JM
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2604-9. PubMed ID: 20133784
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathy.
Bagno LL; Kanashiro-Takeuchi RM; Suncion VY; Golpanian S; Karantalis V; Wolf A; Wang B; Premer C; Balkan W; Rodriguez J; Valdes D; Rosado M; Block NL; Goldstein P; Morales A; Cai RZ; Sha W; Schally AV; Hare JM
J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25827134
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.
Kanashiro-Takeuchi RM; Szalontay L; Schally AV; Takeuchi LM; Popovics P; Jaszberenyi M; Vidaurre I; Zarandi M; Cai RZ; Block NL; Hare JM; Rick FG
Oncotarget; 2015; 6(12):9728-39. PubMed ID: 25797248
[TBL] [Abstract][Full Text] [Related]
5. Agonist of growth hormone-releasing hormone enhances retinal ganglion cell protection induced by macrophages after optic nerve injury.
Cen LP; Ng TK; Liang JJ; Xu C; Zhuang X; Liu YF; Chen SL; Xu Y; Yang Q; Yuan XL; Qin YJ; Chan SO; Chen H; Zhang M; Schally AV; Pang CP
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34244423
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
7. Protection of neonatal rat cardiac myocytes against radiation-induced damage with agonists of growth hormone-releasing hormone.
Kiscsatári L; Varga Z; Schally AV; Gáspár R; Nagy CT; Giricz Z; Ferdinandy P; Fábián G; Kahán Z; Görbe A
Pharmacol Res; 2016 Sep; 111():859-866. PubMed ID: 27480202
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
[TBL] [Abstract][Full Text] [Related]
9. Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival.
Florea V; Majid SS; Kanashiro-Takeuchi RM; Cai RZ; Block NL; Schally AV; Hare JM; Rodrigues CO
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17260-5. PubMed ID: 25404316
[TBL] [Abstract][Full Text] [Related]
10. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
[TBL] [Abstract][Full Text] [Related]
11. Induction of Apoptosis in Pterygium Cells by Antagonists of Growth Hormone-Releasing Hormone Receptors.
Qin YJ; Chu WK; Huang L; Ng CHY; Chan TCY; Cao D; Yang C; Zhang L; Huang SP; Li J; Lin HL; Li WQ; Chen L; Schally AV; Chan SO; Zhang HY; Pang CP
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5060-5066. PubMed ID: 30357400
[TBL] [Abstract][Full Text] [Related]
12. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
[TBL] [Abstract][Full Text] [Related]
13. Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.
Recinella L; Chiavaroli A; Orlando G; Ferrante C; Marconi GD; Gesmundo I; Granata R; Cai R; Sha W; Schally AV; Brunetti L; Leone S
Sci Rep; 2020 Jan; 10(1):732. PubMed ID: 31959947
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
Muñoz-Moreno L; Arenas MI; Schally AV; Fernández-Martínez AB; Zarka E; González-Santander M; Carmena MJ; Vacas E; Prieto JC; Bajo AM
Int J Cancer; 2013 Feb; 132(4):755-65. PubMed ID: 22777643
[TBL] [Abstract][Full Text] [Related]
15. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.
Penna C; Settanni F; Tullio F; Trovato L; Pagliaro P; Alloatti G; Ghigo E; Granata R
Endocrinology; 2013 Apr; 154(4):1624-35. PubMed ID: 23417421
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway.
Guo J; Schally AV; Zarandi M; Varga J; Leung PC
Reprod Biol Endocrinol; 2010 May; 8():54. PubMed ID: 20509930
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
18. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models.
Muñoz-Moreno L; Arenas MI; Carmena MJ; Schally AV; Prieto JC; Bajo AM
Invest New Drugs; 2014 Oct; 32(5):871-82. PubMed ID: 25000999
[TBL] [Abstract][Full Text] [Related]
20. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
